nadp has been researched along with simvastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SS; Chen, YC; Hsieh, CH; Hsieh, MW; Jeng, SF; Lu, TH; Rau, CS | 1 |
| Gerner, C; Grunt, T; Haider, F; Karlic, H; Proestling, K; Thaler, R; Varga, F | 1 |
2 other study(ies) available for nadp and simvastatin
| Article | Year |
|---|---|
Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide.
Topics: Active Transport, Cell Nucleus; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferoxamine; Enzyme Induction; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; I-kappa B Proteins; Iron; Iron Chelating Agents; Lipopolysaccharides; Membrane Proteins; Mice; NADP; Neurons; NF-kappa B; Phosphorylation; Protoporphyrins; Rats; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Simvastatin; Transcription Factor RelA | 2008 |
Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Diphosphonates; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Epigenesis, Genetic; Fatty Acids; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Ibandronic Acid; Lovastatin; Mevalonic Acid; MicroRNAs; NADP; Neoplasms; Protein Processing, Post-Translational; Simvastatin; Vitamin D | 2015 |